Sofinnova Ventures
Latest statistics and disclosures from Sofinnova Investments's latest quarterly 13F-HR filing:
- Top 5 stock holdings are NTRA, VERA, ASND, AVTE, MRK, and represent 31.94% of Sofinnova Investments's stock portfolio.
- Added to shares of these 10 stocks: XBI (+$81M), NVO (+$79M), INCY (+$76M), PODD (+$38M), DYN (+$36M), ALGN (+$31M), AVBP (+$30M), TGTX (+$30M), ARGX (+$28M), BSX (+$24M).
- Started 38 new stock positions in PHVS, ROIV, ALNY, SLNO, COO, CABA, COGT, INCY, TFX, IRON.
- Reduced shares in these 10 stocks: Karuna Therapeutics Ord (-$234M), NTRA (-$142M), Rayzebio (-$54M), AZN (-$52M), DXCM (-$51M), CYTK (-$46M), IWM (-$40M), , , KVUE (-$36M).
- Sold out of its positions in Agenus, AXSM, Cymabay Therapeutics, CYTK, DXCM, EXEL, GRTX, GERN, ImmunoGen, IMVT.
- Sofinnova Investments was a net seller of stock by $-308M.
- Sofinnova Investments has $1.8B in assets under management (AUM), dropping by 13.24%.
- Central Index Key (CIK): 0001631134
Tip: Access up to 7 years of quarterly data
Positions held by Sofinnova Ventures consolidated in one spreadsheet with up to 7 years of data
Download as csv![Download consolidated filings csv](/static/img/csv.png)
![Download consolidated filings xlsx](/static/img/microsoft-excel.png)
Portfolio Holdings for Sofinnova Investments
Sofinnova Investments holds 69 positions in its portfolio as reported in the March 2024 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
---|---|---|---|---|---|---|
Natera (NTRA) | 7.9 | $142M | -50% | 1.6M | 91.46 |
|
Vera Therapeutics Cl A (VERA) | 6.7 | $121M | -19% | 2.8M | 43.12 |
|
Ascendis Pharma A/S Sponsored Adr (ASND) | 6.3 | $114M | 754k | 151.17 |
|
|
Aerovate Therapeutics (AVTE) | 6.2 | $111M | 3.8M | 29.57 |
|
|
Merck & Co (MRK) | 4.8 | $86M | -10% | 651k | 131.95 |
|
Spdr Ser Tr S&p Biotech Put Option (XBI) | 4.5 | $81M | NEW | 850k | 94.89 |
|
Novo-Nordisk A S Adr (NVO) | 4.4 | $79M | NEW | 612k | 128.40 |
|
Incyte Corporation (INCY) | 4.2 | $76M | NEW | 1.3M | 56.97 |
|
Argenx SE Sponsored Adr (ARGX) | 3.3 | $59M | +90% | 149k | 393.72 |
|
Intuitive Surgical (ISRG) | 3.1 | $56M | -18% | 141k | 399.09 |
|
Dyne Therapeutics (DYN) | 3.1 | $55M | +182% | 1.9M | 28.39 |
|
Inhibrx | 2.5 | $46M | +75% | 1.3M | 34.96 |
|
Elanco Animal Health (ELAN) | 2.3 | $42M | -29% | 2.6M | 16.28 |
|
IDEXX Laboratories (IDXX) | 2.3 | $41M | -3% | 75k | 539.93 |
|
AstraZeneca Sponsored Adr (AZN) | 2.3 | $40M | -56% | 597k | 67.75 |
|
Syndax Pharmaceuticals (SNDX) | 2.1 | $38M | -19% | 1.6M | 23.80 |
|
Insulet Corporation (PODD) | 2.1 | $38M | NEW | 220k | 171.40 |
|
Y Mabs Therapeutics (YMAB) | 2.0 | $36M | 2.2M | 16.26 |
|
|
Ideaya Biosciences (IDYA) | 1.9 | $34M | -24% | 782k | 43.88 |
|
Celldex Therapeutics (CLDX) | 1.9 | $34M | +28% | 802k | 41.97 |
|
Inozyme Pharma (INZY) | 1.8 | $33M | 4.3M | 7.66 |
|
|
Align Technology (ALGN) | 1.7 | $31M | NEW | 96k | 327.92 |
|
Arrivent Biopharma (AVBP) | 1.7 | $30M | NEW | 1.7M | 17.86 |
|
Tg Therapeutics (TGTX) | 1.7 | $30M | NEW | 2.0M | 15.21 |
|
Sarepta Therapeutics (SRPT) | 1.6 | $30M | +345% | 228k | 129.46 |
|
Marinus Pharmaceuticals (MRNS) | 1.6 | $29M | +149% | 3.3M | 9.04 |
|
Boston Scientific Corporation (BSX) | 1.4 | $24M | NEW | 354k | 68.49 |
|
Immatics NV SHS (IMTX) | 1.3 | $23M | -33% | 2.2M | 10.51 |
|
Silk Road Medical Inc Common (SILK) | 1.2 | $22M | NEW | 1.2M | 18.32 |
|
Cogent Biosciences (COGT) | 0.9 | $16M | NEW | 2.4M | 6.72 |
|
EXACT Sciences Corporation (EXAS) | 0.9 | $16M | NEW | 230k | 69.06 |
|
Alnylam Pharmaceuticals (ALNY) | 0.9 | $15M | NEW | 103k | 149.45 |
|
Immunome (IMNM) | 0.8 | $15M | NEW | 594k | 24.68 |
|
Pharvaris N V (PHVS) | 0.8 | $14M | NEW | 585k | 23.11 |
|
Savara (SVRA) | 0.7 | $12M | +1386% | 2.3M | 4.98 |
|
Shockwave Med | 0.6 | $11M | NEW | 35k | 325.63 |
|
Kura Oncology (KURA) | 0.6 | $11M | NEW | 502k | 21.33 |
|
Roivant Sciences SHS (ROIV) | 0.6 | $11M | NEW | 1.0M | 10.54 |
|
Axonics Modulation Technolog (AXNX) | 0.6 | $10M | NEW | 149k | 68.97 |
|
Pepgen (PEPG) | 0.4 | $7.4M | NEW | 504k | 14.70 |
|
Cabaletta Bio (CABA) | 0.4 | $7.3M | NEW | 430k | 17.06 |
|
Establishment Labs Holdings Ord (ESTA) | 0.4 | $7.2M | NEW | 141k | 50.90 |
|
Achieve Life Sciences (ACHV) | 0.4 | $6.9M | NEW | 1.5M | 4.54 |
|
Soleno Therapeutics (SLNO) | 0.4 | $6.5M | NEW | 151k | 42.80 |
|
4d Molecular Therapeutics In (FDMT) | 0.4 | $6.3M | NEW | 198k | 31.86 |
|
Nextcure (NXTC) | 0.3 | $6.0M | 2.7M | 2.23 |
|
|
Avantor (AVTR) | 0.3 | $5.9M | NEW | 232k | 25.57 |
|
Madrigal Pharmaceuticals (MDGL) | 0.3 | $5.1M | NEW | 19k | 267.04 |
|
Bolt Biotherapeutics (BOLT) | 0.2 | $3.9M | 2.8M | 1.40 |
|
|
Fusion Pharmaceuticals | 0.2 | $3.4M | +34% | 157k | 21.32 |
|
Masimo Corporation (MASI) | 0.2 | $2.9M | NEW | 20k | 146.85 |
|
Teleflex Incorporated (TFX) | 0.2 | $2.7M | NEW | 12k | 226.17 |
|
Insmed Com Par $.01 Call Option (INSM) | 0.2 | $2.7M | NEW | 100k | 27.13 |
|
Cooper Cos (COO) | 0.1 | $2.2M | NEW | 21k | 101.46 |
|
Inspire Med Sys (INSP) | 0.1 | $1.7M | NEW | 8.1k | 214.79 |
|
Amylyx Pharmaceuticals (AMLX) | 0.1 | $1.7M | NEW | 607k | 2.84 |
|
LivaNova SHS (LIVN) | 0.1 | $1.1M | NEW | 21k | 55.94 |
|
Nucana Sponsored Adr | 0.0 | $884k | -39% | 3.4M | 0.26 |
|
Baxter International (BAX) | 0.0 | $855k | NEW | 20k | 42.74 |
|
Immatics NV *w Exp 07/01/2025 (IMTXW) | 0.0 | $853k | 316k | 2.70 |
|
|
Pds Biotechnology Ord (PDSB) | 0.0 | $565k | 143k | 3.96 |
|
|
IsoRay (CATX) | 0.0 | $512k | NEW | 430k | 1.19 |
|
Inari Medical Ord (NARI) | 0.0 | $490k | NEW | 10k | 47.98 |
|
Disc Medicine (IRON) | 0.0 | $384k | NEW | 6.2k | 62.26 |
|
Structure Therapeutics Sponsored Ads (GPCR) | 0.0 | $374k | -95% | 8.7k | 42.86 |
|
Nucana Common Shares | 0.0 | $340k | -45% | 1.3M | 0.26 |
|
Kyverna Therapeutics (KYTX) | 0.0 | $248k | NEW | 10k | 24.84 |
|
Ikena Oncology (IKNA) | 0.0 | $164k | 116k | 1.42 |
|
|
Mirum Pharmaceuticals (MIRM) | 0.0 | $76k | -66% | 3.0k | 25.12 |
|
Past Filings by Sofinnova Investments
SEC 13F filings are viewable for Sofinnova Investments going back to 2018
- Sofinnova Investments 2024 Q1 filed May 15, 2024
- Sofinnova Investments 2023 Q3 filed Nov. 14, 2023
- Sofinnova Investments 2023 Q2 filed Aug. 14, 2023
- Sofinnova Investments 2023 Q1 filed May 11, 2023
- Sofinnova Investments 2022 Q4 filed Feb. 14, 2023
- Sofinnova Investments 2022 Q3 filed Nov. 8, 2022
- Sofinnova Investments 2022 Q2 filed Aug. 15, 2022
- Sofinnova Investments 2022 Q1 filed May 16, 2022
- Sofinnova Investments 2021 Q4 filed Feb. 14, 2022
- Sofinnova Investments 2021 Q3 filed Nov. 15, 2021
- Sofinnova Investments 2021 Q2 filed Aug. 16, 2021
- Sofinnova Investments 2021 Q1 filed May 14, 2021
- Sofinnova Investments 2020 Q4 filed Feb. 16, 2021
- Sofinnova Investments 2020 Q3 filed Nov. 13, 2020
- Sofinnova Investments 2020 Q2 filed Aug. 13, 2020
- Sofinnova Investments 2020 Q1 filed May 13, 2020